Media

GigaGen and Trianni Announce License Agreement for Discovery of Fully Human Immuno-Oncology Antibodies

Partnership leverages GigaGen’s industry-leading immune repertoire sequencing and expression technology and Trianni’s best-in-class human transgenic mouse platform. February 28, 2017– […]



Continue reading

TRIANNI Signs Agreement with Stanford University for Use of The Trianni Mouse in Vaccine Research

San Francisco, CA, USA., February 22, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement […]



Continue reading

TRIANNI Signs Licensing Agreement for Transgenic Mouse Platform Use with Janssen

San Francisco, CA, USA., February 15, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement […]



Continue reading